Special Issue "Antitumor Potential and Side Effects of Natural and Synthetic Compounds"
A special issue of Medicines (ISSN 2305-6320).
Deadline for manuscript submissions: closed (31 March 2021).
Interests: informatics; information network; pharmacy; biological pharmacy; basic medicine; general pharmacology; boundary medicine; laboratory medicine; dentistry
Special Issues and Collections in MDPI journals
Special Issue in Medicines: Research Topics in Medicines and How Our Board Members Are Engaged in Them
Special Issue in Medicines: Anti-pandemic: Search for New Therapeutics from the Natural Kingdom and Laboratory
Although many antitumor substances have been isolated from the natural kingdom, most authors have shown their cytotoxicity against malignant cells, but not against non-malignant cells. Recently, synthetic compounds of chromones and α,β-unsaturated ketones have shown very high antitumor potential, sometimes exceeding that of anticancer drugs.
This Special Issue calls for papers exploring the antitumor potential of natural and synthetic compounds against both malignant and non-malignant cells and their adverse effects. The papers that focus on the exploration of preparative or synthetic methods and the elucidation of action mechanisms are also within the scope of this issue.
Prof. Dr. Hiroshi Sakagami
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.